GlassScriptPhysician profile
Stanley S Tu
NPI 1215011879
$3,832.36
in general payments reported to CMS, 2019-2025
35 companies · $1,242 in 2025
The $1,242 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $80.34 · 2021: $121 · 2022: $544 · 2023: $670 · 2024: $1,036 · 2025: $1,242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,948.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $553.74 | 2020-2025 | Ofev, Jascayd |
| Harmony Biosciences LLC | $544.83 | 2022-2025 | Wakix |
| Grifols USA, LLC | $374.30 | 2019-2025 | Prolastin-C Liquid |
| Glaxosmithkline, LLC. | $337.73 | 2019-2025 | Trelegy Ellipta, Nucala |
| Merck Sharp & Dohme LLC | $227.54 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| Axsome Therapeutics, INC. | $204.98 | 2023-2025 | Sunosi |
| Regeneron Healthcare Solutions, INC. | $145.98 | 2021-2024 | Dupixent |
| Verona Pharma, INC. | $143.34 | 2025 | Ohtuvayre |
| Pulmonx Corporation | $119.43 | 2023-2025 | Chartis Catheter, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| United Therapeutics Corporation | $114.50 | 2023-2025 | Tyvaso, Tyvaso |
| Novo Nordisk INC | $106.71 | 2023-2025 | Rybelsus, Ozempic |
| Mallinckrodt Hospital Products INC. | $78.78 | 2024-2025 | Acthar |
| Viatris Specialty LLC | $74.03 | 2025 | Yupelri |
| Avadel Cns Pharmaceuticals, LLC | $66.18 | 2023-2025 | Lumryz |
| Mylan Specialty L.P. | $62.45 | 2019-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $62.39 | 2022-2024 | |
| Pfizer INC. | $59.92 | 2022-2024 | |
| Baxter Healthcare | $58.26 | 2023-2024 | Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System |
| Bausch Health US, LLC | $48.03 | 2020-2021 | |
| Ani Pharmaceuticals, INC. | $46.77 | 2024 | Purified Cortrophin Gel |
| Optinose US, INC. | $41.71 | 2024-2025 | |
| Philips North America LLC | $40.23 | 2025 | Sleep Service, Vest Therapy Und |
| Idorsia Pharmaceuticals US INC | $37.49 | 2023 | Quviviq |
| Jazz Pharmaceuticals INC. | $37.25 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $29.65 | 2021 | |
| Caris Mpi, INC. | $29.27 | 2025 | Mi Cancer Seek |
| Vanda Pharmaceuticals INC. | $24.97 | 2023 | Hetlioz |
| Inspire Medical Systems, INC. | $24.90 | 2024 | Inspire |
| Electromed, INC. | $24.77 | 2019-2024 | Smartvest |
| Sunovion Pharmaceuticals INC. | $22.68 | 2019 | |
| Abbvie INC. | $21.06 | 2019 | |
| Exact Sciences Corporation | $19.52 | 2025 | Cologuard Collection Kit |
| Actelion Pharmaceuticals US, INC. | $18.91 | 2024 | Uptravi, Opsumit |
| Amarin Pharma, INC. | $18.38 | 2020 | |
| Phadia US INC. | $11.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Tu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.